Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Corbett

Showing results (491-500 of 576) with videos related to

Pageof 58
Sort By:
Journal of Autism and Developmental Disorders|March 14, 2017
Characterizing Sleep in Adolescents and Adults with Autism Spectrum DisordersS E Goldman, M L Alder, H J Burgess, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|April 15, 2024
Zinc-chelating BET bromodomain inhibitors equally target islet endocrine cell typesRachel A Jones Lipinski, Jennifer S Stancill, Raymundo Nuñez, et al.
Advances in Enzyme Regulation|January 1, 1991
Glycogen metabolism and signal transduction in mammals and yeastP J Roach, Y Cao, C A Corbett, et al.
The Journal of Biological Chemistry|January 5, 1996
Regulation of inducible nitric oxide synthase expression by macrophage purinoreceptors and calciumL C Denlinger, P L Fisette, K A Garis, et al.
Human Molecular Genetics|March 27, 2021
Transgenic mice with an R342X mutation in Phf6 display clinical features of Börjeson-Forssman-Lehmann SyndromeRaies Ahmed, Shihab Sarwar, Jinghua Hu, et al.
The Journal of Biological Chemistry|February 11, 2023
β-cell-selective inhibition of DNA damage response signaling by nitric oxide is associated with an attenuation in glucose uptakeChay Teng Yeo, Erin M Kropp, Polly A Hansen, et al.
Human Molecular Genetics|February 7, 2001
A mutation in alpha-tropomyosin(slow) affects muscle strength, maturation and hypertrophy in a mouse model for nemaline myopathyM A Corbett, C S Robinson, G F Dunglison, et al.
Diabetes|April 11, 1992
Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunctionJ A Corbett, R G Tilton, K Chang, et al.
European Journal of Immunology|February 4, 2009
The CDK domain of p21 is a suppressor of IL-1beta-mediated inflammation in activated macrophagesJohn C Scatizzi, Melissa Mavers, Jack Hutcheson, et al.
Developmental Medicine and Child Neurology|June 17, 2020
Definition and diagnosis of cerebral palsy in genetic studies: a systematic reviewRyan Pham, Ben W Mol, Jozef Gecz, et al.
Pageof 58

Showing results (491-500 of 576) with videos related to

Sort By:
Pageof 58
Journal of Autism and Developmental Disorders|March 14, 2017
Characterizing Sleep in Adolescents and Adults with Autism Spectrum DisordersS E Goldman, M L Alder, H J Burgess, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|April 15, 2024
Zinc-chelating BET bromodomain inhibitors equally target islet endocrine cell typesRachel A Jones Lipinski, Jennifer S Stancill, Raymundo Nuñez, et al.
Advances in Enzyme Regulation|January 1, 1991
Glycogen metabolism and signal transduction in mammals and yeastP J Roach, Y Cao, C A Corbett, et al.
The Journal of Biological Chemistry|January 5, 1996
Regulation of inducible nitric oxide synthase expression by macrophage purinoreceptors and calciumL C Denlinger, P L Fisette, K A Garis, et al.
Human Molecular Genetics|March 27, 2021
Transgenic mice with an R342X mutation in Phf6 display clinical features of Börjeson-Forssman-Lehmann SyndromeRaies Ahmed, Shihab Sarwar, Jinghua Hu, et al.
The Journal of Biological Chemistry|February 11, 2023
β-cell-selective inhibition of DNA damage response signaling by nitric oxide is associated with an attenuation in glucose uptakeChay Teng Yeo, Erin M Kropp, Polly A Hansen, et al.
Human Molecular Genetics|February 7, 2001
A mutation in alpha-tropomyosin(slow) affects muscle strength, maturation and hypertrophy in a mouse model for nemaline myopathyM A Corbett, C S Robinson, G F Dunglison, et al.
Diabetes|April 11, 1992
Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunctionJ A Corbett, R G Tilton, K Chang, et al.
European Journal of Immunology|February 4, 2009
The CDK domain of p21 is a suppressor of IL-1beta-mediated inflammation in activated macrophagesJohn C Scatizzi, Melissa Mavers, Jack Hutcheson, et al.
Developmental Medicine and Child Neurology|June 17, 2020
Definition and diagnosis of cerebral palsy in genetic studies: a systematic reviewRyan Pham, Ben W Mol, Jozef Gecz, et al.
Pageof 58